TDUP:NASDAQThredUp Inc. Analysis
Data as of 2026-05-04 - not real-time
$4.33
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
ThredUp (TDUP) is trading at $4.33, comfortably above its 20‑day ($4.15) and 50‑day ($3.92) SMAs but still well below the 200‑day SMA of $7.06, indicating short‑term momentum within a longer‑term downtrend. The MACD histogram is positive and the signal line is bullish, while the RSI sits at a neutral 57, suggesting modest buying pressure. Recent news of resilient U.S. apparel sales helped the stock jump 4.6%, reinforcing short‑term optimism.
Fundamentally, the company posts solid top‑line growth (18.5% YoY revenue increase) and a strong gross margin (~79%), yet it remains loss‑making with negative operating and profit margins, a high debt‑to‑equity ratio (~88%), and a price‑to‑book of 9.3, far above its DCF fair value of $2.47. Positive operating cash flow and free cash flow provide a cushion, but the high beta (1.77) and 30‑day volatility (~59%) amplify risk.
Fundamentally, the company posts solid top‑line growth (18.5% YoY revenue increase) and a strong gross margin (~79%), yet it remains loss‑making with negative operating and profit margins, a high debt‑to‑equity ratio (~88%), and a price‑to‑book of 9.3, far above its DCF fair value of $2.47. Positive operating cash flow and free cash flow provide a cushion, but the high beta (1.77) and 30‑day volatility (~59%) amplify risk.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD and recent positive consumer‑spending data
- Price hovering near short‑term support levels
- High volatility and decreasing volume signal caution
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong revenue growth and high gross margin
- Positive operating and free cash flow offsets loss backdrop
- Analyst consensus of strong‑buy and target price upside
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Persistent operating losses and high leverage
- Significant overvaluation versus DCF and book value
- Potential for improved profitability as the resale market matures
Key Metrics & Analysis
Financial Health
Revenue Growth18.50%
Profit Margin-6.50%
P/E Ratio-55.4
ROE-35.00%
ROA-7.64%
Debt/Equity88.07
P/B Ratio9.3
Op. Cash Flow$10.7M
Free Cash Flow$11.3M
Technical Analysis
TrendNeutral
RSI57.3
Support$3.45
Resistance$4.86
MA 20$4.15
MA 50$3.92
MA 200$7.06
MACDBullish
VolumeDecreasing
Fear & Greed Index87.82
Valuation
Fair Value$2.47
Target Price$8.80
Upside/Downside103.47%
GradeOvervalued
TypeBlend
Risk Assessment
Beta1.77
Volatility59.13%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.